Daily Stock Market Report (Tue 5th August 2025) - DOM, ZTF, SQZ, BP., MCON, DGE, YOU
Good morning!
Today's Agenda is complete. It's a busy Tuesday, which we've grown accustomed to!
Spreadsheet accompanying this report: link (last updated: 10th July) (work-in progress).
Companies Reporting
| Name (Mkt Cap) | RNS | Summary | Our view (Author) |
|---|---|---|---|
BP (LON:BP.) (£64bn) | Q2 underlying replacement cost profit $2.4bn, ahead of exps for $1.8bn (Reuters). Q2 op. cash flow $6.3bn. Ordinary divi +4% to 8.32 cents. | AMBER (Roland) [no section below] Today’s results reveal that the BP CEO has already been in talks with incoming chair Albert Manifold about another strategic review, just a few months after the company’s “fundamental reset”. I think this could be worth doing though, given Manifold’s track record of creating value for shareholders when he was CEO of CRH (see my comments yesterday). Elsewhere, BP says its $20bn disposal plan remains on track with “tons of interest” in flagship lubricants group Castrol. Overall profits today appear to be ahead of expectations, thanks partly to a further $0.9bn of cost savings in H1. Debt levels remain a bit of a headache. Net debt fell slightly to $26.0bn relative to Q1, but remains c.$3.5bn higher than at the same point last year. This is a little higher than I’d like to see for a cyclical business that generates rather average returns on capital. Although the company is targeting net debt of $14-$18bn by the end of 2027, this seems to rely on a major disposal being achieved. Rather like Diageo, I think BP is now in a holding position awaiting new strategic leadership. Given the absence of any new downgrades today and the 6% dividend yield on offer, I’m going to revert our view to neutral. | |
Diageo (LON:DGE) (£40bn) | FY25 in line. Adj. op profit -0.7%, actual op profit -28%. Net debt/EBITDA leverage at 3.4x. FY26 outlook: mid single digit organic op profit growth. | AMBER (Roland) These results seem no worse than expected, but highlight a continued sales decline in many of the group’s core categories. The interim CEO doesn’t provide much in the way of strategy update but has increased cost saving targets, reiterating plans to reduce leverage by FY28. Although the shares are cheap by historical standards, it’s not clear to me what will be required to return the business to a healthier position. I’m inclined to remain neutral until a permanent CEO is appointed or there is evidence of improving trading. | |
Fresnillo (LON:FRES) (£11bn) | Gold guidance up, silver guidance “adjusted”. In terms of equivalent silver oz, guidance unchanged. | ||
Smith & Nephew (LON:SN.) (£10bn) | Q2 rev +8%, underlying growth +7%. Op profit +31% ($429m). Guidance unchanged. | ||
Spectris (LON:SXS) (£4.1bn) | £41.75 in cash from KKR, plus interim dividend 28p. This is now the fourth recommended offer. | PINK | |
Rotork (LON:ROR) (£2.65bn) | Order intake +6.3% (like-for-like). H1 adj. op profit +5.7% (£80.8m). Expectations unchanged. | ||
Big Yellow (LON:BYG) (£1.83bn) | New 70,000 sq ft store in West London, serving a new catchment area. 3 more to open this year. | ||
GlobalData (LON:DATA) (£1.2bn) | Slower start to the year, expects to regain adj. EBITDA margin in H2. Op profit -25%. £60m tender offer. | ||
Travis Perkins (LON:TPK) (£1.14bn) | Stabilised market share in Q2. Uncertain market outlook, but expecting to be broadly in line. | ||
Spirent Communications (LON:SPT) (£1.13bn) | Takeover: cash offer remains subject to satisfaction/waiver of remaining conditions. | PINK | |
Domino's Pizza (LON:DOM) (£917m) | H1 adj. PBT -32%. Lower adj. EBITDA guidance £130-140m (consensus: £140.8-149.2m). | BLACK (AMBER/RED) (Graham) I've long had an interest in this company, but it has never been cheap enough for me. The share price is now at lows not seen in over a decade, and I do think it is starting to offer some value. However, the balance sheet is unappetising and I can see arguments both for and against an investment in the stock at current levels. Using our framework that profit warnings tend to be followed by more profit warnings, I'm downgrading our stance by one notch today. | |
Keller (LON:KLR) (£940m) | H1 adj. op profit -9% is ahead of exps, full year expectations maintained despite FX headwind. | ||
Serica Energy (LON:SQZ) (£619m) | Should soon return to c. 50k boepd, more to come. Production guidance for 2025: 33-35k boepd. H1 prod -43% to 24.7k boepd. EBITDAX -58% to $179m. Pre-tax loss of $43m. Interim dividend -33% to 6p | AMBER/GREEN (Roland) [no section below] | |
Harworth (LON:HWG) (£609m) | Time to conclude deals remains elongated. Valuation headwinds, cost increases at residential sites. | ||
YouGov (LON:YOU) (£360m) | SP +17% FY25 to be in line with expectations reflecting full year impact of the CPS acquisition, with modest organic growth. On track to realise cost savings of £20m. FY26: "encouraging". | AMBER (Graham) [no section below] After a protracted period of share price weakness and declining earnings estimates, the market loves this sturdy trading update. From the last set of half-year results, I see that net debt was £154.7m, with a high leverage multiple of 2x. The forecast P/E multiple is only 8x but it's more expensive when you take that leverage into account, and also when you consider that historic earnings figures have been very heavily adjusted. Still, I don't see the need to be AMBER/RED on this: I reserve that colour for fundamentally bad companies, or higher-quality companies that are experiencing short-term weakness. I don't think YouGov is a fundamentally bad company, and current trading is apparently quite good - described by management as "stable", with an encouraging outlook. YouGov itself is a valuable brand and I think AMBER/RED would be a little harsh after today's update. So let's go back to neutral. | |
| Capita (LON:CPI) (£320m) | Interim Results | Rev -4%, adj op profit -22% to £42.6m. Contract wins +17% YoY. FY exps unchanged. | |
XP Power (LON:XPP) (£238m) | Order intake +31% to £112.7m, rev -13%, adj op profit -64% to £4.8m. FY25: “range of outcomes” | ||
Genel Energy (LON:GENL) (£166m) | Production stable at 19.6k bopd. Op loss $2.5m, free cash flow $4.7m. Drone attack in July. | ||
SIG (LON:SHI) (£160m) | Rev -1%, adj LBT of £10.3m. Leverage 4.9x. FY25 outlook unchanged. | ||
Seeing Machines (LON:SEE) (£137m) | Production +36% vs Q3, FY25 prod volumes >1.5m (+35%). Target neutral cash flow in FY26. | ||
Zotefoams (LON:ZTF) (£137m) | H1 sales +9%, PBT +37% to £11.4m. Improved margins. FY adj PBT to be ahead of exps. | GREEN (Roland) Solid figures show organic growth and the additional improvement in profitability I expected to see as a result of the curtailed MEL business. I’m a little concerned by the weaker outlook for H2, but reassured by today’s upgrade to profit guidance for 2025. The shares continue to look affordable to me. On the basis of today’s improved profitability and earnings upgrade I’ve left my positive view unchanged. | |
Synthomer (LON:SYNT) (£129m) | Rev -9.8%, adj op profit +0.4% to £28.3m. Lower volumes, higher margin. Leverage at 4.8x. | ||
Software Circle (LON:SFT) (£111m) | Total consideration up to €9m for Online Application platform. AIF “expected EBIT” of €0.7m. | ||
Mincon (LON:MCON) (£69m) | Rev +9%, op profit €4.1m. Significant recovery in margins due to savings and volume gains. | AMBER/GREEN (Graham) | |
Dewhurst (LON:DWHA) (£61m) | Delisting to become private company. £25m tender offer for 665p (DWHA) and 900p (DWHT) | PINK | |
Naked Wines (LON:WINE) (£58m) | FY25 results in line. Rev -14%, adj EBITDA -23% to £6.7m Inventory reduced to £108m. | ||
CML Microsystems (LON:CML) (£49m) | Recently won 12yr contract worth >$30m. Trading in line to meet FY exps, with H2 weighting. | ||
Gelion (LON:GELN) (£44m) | Integrated Gelion Sulfur Cathode into Li-S coin cells, “outstanding performance” in testing. | ||
Orosur Mining (LON:OMI) (£33m) | Drilling program underway to convert Pepas to resource estimate by year end. | ||
Cyanconnode Holdings (LON:CYAN) (£28m) | Follow-on order for AED 5.8m (£1.2m) for cellular gateways. Revenue recognised in current FY. | ||
Gattaca (LON:GATC) (£28m) | FY25 adj PBT to be £3.1-3.3m (above exps of £3m). FY26 exps in line for adj PBT of £4m. | ||
Tungsten West (LON:TUN) (£16m) | Project economics remain unchanged with IRR of 29% and NPV (7.5%) of $190m at $400m/t. | ||
Abingdon Health (LON:ABDX) (£13m) | FY25 revenue in line with exps of £8.6m. Targeting further growth and positive cash flow in FY26. |
Graham's Section
Domino's Pizza (LON:DOM)
Down 14% to 211.39p (£827m) - Half-year Results - Graham - BLACK (AMBER/RED)
For many years I’ve perceived this as a fairly boring large-cap, with a high rating that was prohibitive for those of us who like searching for bargains.
However, perhaps that is changing.
For one thing, the market cap is now well below £1bn, suggesting that it has returned to mid-cap territory.
See how the share price has gone nowhere in 10 years - in fact it has fallen through the bottom of its 10-year range.
The P/E multiple has typically been in the teens or low 20s.
But that rating has grown cheaper as the market has apparently lost confidence in the quality of the company.
Note the downward trend in EPS forecasts:
And today we have a full-blown profit warning with the company’s half-year results.
Highlights from the H1 numbers:
System sales +1.3% (£778m)
Revenue +1.4% (£332m)
Underlying PBT -14.8% (£44m)
These numbers don’t tell the whole story: like-for-like sales (i.e. focusing on mature stores) fell by 0.1%, with Q2 worse than Q1 at minus 0.7%.
11 stores opened, which was lower than expected: “franchisees cautious given increased employment costs”.
Despite falling profits, they still raise their interim dividend slightly to 3.6p.
New guidance: underlying EBITDA £130-140m.
Market share: up slightly, including a sharp gain in the UK pizza sub-sector to 53.7%. That seems positive to me, as I think it means the company is generally suffering from macro conditions rather than being out-competed.
CEO comment finishes confidently but first it lays out the bad news:
"Against a more difficult market backdrop, Domino's is significantly increasing its market share by offering great value, innovative products and even faster delivery times..
"There's no getting away from the fact that the market has become tougher both for us and our franchisees, and that's meant that the positive performance across the first four months didn't continue into May and June. Given weaker consumer confidence, increased employment costs and uncertainty ahead of the Autumn Statement, franchisees are taking a more cautious approach to store openings for the time being…
A second brand? They’d like to buy another brand, but haven’t pulled the trigger yet.
No opportunities under current consideration would require equity issuance
Whilst a second brand remains a core part of the strategy, if no acquisition announced by end of 2025, Board expects to resume share buybacks
Net debt is £307m, which gives a leverage multiple of 2.3x. I’d rate that as aggressive, although I think a company like Domino’s (capital-light and somewhat predictable) should be able to manage it. Their guidance for year-end is net debt of between £260-280m.
They don’t seem concerned about leverage given that they are hunting for acquisitions, might resume buybacks instead and, as I’ve already mentioned, have just increased their dividend.
Balance sheet: as a financially leveraged franchisor I’m not surprised to see that there is little balance sheet support. The position is a bit worse than it needs to be, however: equity is minus £83m or minus £220m if we remove intangibles from the equation. The company runs a negative working capital position which is a luxury. But as someone with value investor instincts, it doesn’t fill me with confidence to see a balance sheet like this.
Cash flow: there is no doubt that the core business is generating cash, but they are flying a little close to the sun for my liking. Interest is being paid out at £16m annually, and dividends are costing £42m. That’s a lot of outflows before we get into paying for anything else.
Cash generated from operating activities, after taxes paid, was £103.5m last year, and £37m in H1 this year.
New estimates: thanks to Panmure Liberum for publishing on DOM today.
They note that the midpoint of the new adj. EBITDA guidance is a 7.5% cut against prior expectations.
As for PanLib’s own estimates, they suggest adj. PBT this year of £94.4m (previous forecast: £107.7m), which is a 12% cut.
They also cut 2026 and 2027 PBT estimates by 13-14%.
Adjusted earnings per share estimates receive similar percentage cuts and the new EPS forecast for the current year is 18.4p.
At the latest share price, that puts the company on a P/E multiple for the current year of 11.4x.
Graham’s view
I must admit that I’m a tiny bit tempted by the new earnings multiple, as this is a business that I’ve always rated highly, but that has always been too expensive for me. So when I see it "on sale", I'm going to sit up and take notice.
It’s no longer expensive, but the trade-off for that is declining profitability.
If you believe the estimates, PBT is going to start picking up again very quickly, in 2026.
Let’s sum up a few positives and negatives.
Pros:
Universally recognised brand
Very high market share with majority market share in pizza takeaway.
Capital-light franchise model. Should be highly profitable. ROCE 31% according to the StockReport.
Cons:
Economic sensitivity to the consumer is producing some weakness in the short-term.
Zero balance sheet support. An aggressive leverage multiple and highly negative net tangible assets.
Impossible to predict whether the company will be able to successfully acquire and manage a second brand. At least it sounds as if they are not currently looking at any very large deals, if equity issuance would not be required.
In case you can’t tell, I’m on the fence on this one! On a long-term view, I do think it’s starting to look interesting, for investors who aren’t put off by the shaky balance sheet.
But using our framework which warns that profit warnings tend to be followed by more profit warnings, I’m going to have to go AMBER/RED on it today.
That’s only a one-notch downgrade, as Roland was AMBER on it last December.
I’ll have no problem upgrading it again once it’s clear that the position has stabilised.
The UK economy shrank in April and May, and I’m reminded of the bearish warnings we heard the other day from Next (LON:NXT) (which I own) that recent tax changes will dampen employment and consumer spending in H2. So I think we do need to weigh up the risk that further economic softness could hurt the likes of Domino’s in the second half of the year, and even the new estimates might be difficult to meet.
Mincon (LON:MCON)
Up 5% to 33.45p (£72m / €83m) - Half-year Report - Graham - AMBER/GREEN
Mincon Group plc (Euronext:MIO AIM:MCON), the Irish engineering group specialising in the design, manufacture, sale and servicing of rock drilling tools and associated products, announces its half year results for the six months ended 30 June 2025.
I’ve wanted to be more positive on this one but haven’t quite managed to get off a neutral stance recently. The last time I wrote a full section on Mincon was in March.
Key points today:
H1 revenue +9% (€74m)
Gross profit +27% (€22m)
Operating profit €4.1m (H1 last year: €0.2m)
Profit €0.7m (H1 last year: €1m loss).
Well done to the company for finding “operational and sourcing efficiencies”. Along with volume recovery, this leads to a significant increase in gross margin.
Greenhammer: this has been years in the making, but at last there is a “cost per foot” contract starting in Arizona:
Our Greenhammer project is ready to deliver a yearlong cost per foot contract on a copper mine in Arizona. We have a team and service facility in place. This will be delivered in conjunction with our rig manufacturer partner and we are both optimistic about its future prospects.
CEO comment:
"I am pleased to report that the first half of 2025 showed a return to growth with higher revenue than the prior year but more importantly a significant recovery in our margins. This improved performance has been driven by increases in our construction revenues. This strong construction performance is due to a combination of our superior engineered product offering as well as onsite service support.
In conjunction with our improved sales, we have continued our focus on driving operational efficiencies across the Group, which is enhancing our margins and competitiveness.
Construction has grown from 36% of revenue in H1 last year, to 48% of revenue in H1 this year. Mining has moved in the opposite direction.
Outlook
The company’s improvement in margin is “ongoing”. They don’t provide an outlook statement specifically, but they do offer the following conclusion - and I appreciate the focus on ROCE.:
It is pleasing to see the progress that we are making in the first half of this year. It does demonstrate that our business is moving in the right direction to increase revenues and more importantly margins and ROCE.
The increased opportunity we see in construction should be supplemented by growth that our product development can unlock in mining and in time with renewables. We are building positive momentum, and we need to remain focused on improving our competitive position, while delivering on the opportunities we have worked so hard to create. I would like to thank our dedicated teams around the world for their continued efforts and look forward to brighter days ahead.
Cash/balance sheet
The company’s “balance sheet” section of the financial review barely doesn’t lead with any numbers, which is rarely a good sign. Investors are left to calculate net debt ourselves, and I come up with a figure of €23m. As of Dec 2024, the corresponding calculation is around the same.
Graham’s view
So, can I get this stock off AMBER? Yes, I think I’ll give it the benefit of the doubt.
Positives:
Has shown it’s not dependent on the (highly volatile) mining sector, diversifying very nicely into construction.
Improved margins give it a higher-quality profile.
Management voluntarily highlights the importance of ROCE (not all management teams do this!).
Greenhammer seems to be closer than ever to making a meaningful contribution.
Negatives? The main negative is that the debt picture is not ideal, but I think it’s manageable.
An interesting company that’s not particularly expensive and showing signs of life - AMBER/GREEN makes sense to me now.
Roland's Section
Zotefoams (LON:ZTF)
Up 20% to 334p (£165m) - Interim Results & JV Agreement - Roland - GREEN
Given the strong H1 2025 performance and momentum carried into the second half, the Board now expects to deliver full year underlying profit before taxation ahead of current market expectations.
Record results and upgraded guidance from this specialist foam business have met with a positive – almost rapturous – reception today from investors.
The numbers are certainly positive and appear to provide strong vindication for the strategic shift CEO Ronan Cox has led since his appointment.
H1 highlights - here’s a summary of the key numbers:
Revenue up 9% to £77.4m
Operating margin improved to 12.2% (H1 24: 9.7%)
Pre-tax profit up 37% to £11.4m
Net debt down 35% to £29.1m
Interim dividend +5% to 2.5p per share
I think there are two factors underlying the improvement in profits and margins this year.
One of these is the exclusion of the loss-making MEL (Rezorce) business, which was discontinued last year. In February, I modelled how this might affect Zotefoams’ profitability – doing this highlighted the affordability of FY25 forecasts, so I’m pleased to see this reflected in today’s results.
The other positive factor today is the evidence of genuine top line growth, which seems to have been driven by a mix of price and volume (credit to Zotefoams for making this clear):
EMEA region: revenue up 11% to £61.4m, including 8% volume growth. This increase was largely driven by consumer sales. Much of this was driven by a 5% increase in demand from the group’s largest customer, Nike (NYQ:NKE), which is using Zotefoams’ ZoomX product in a growing range of its shoes. Revenue from the transport and construction sectors were broadly flat.
North America: revenue rose by 10% to £14.5m, including 5% volume growth. Transport & Smart Technologies was the key contributor here, with sales up 49% to £8.8m thanks to a good performance in the aerospace and specialty packaging segments
Asia: revenue fell by a third to £1.4m, but this region is currently seen as “an immaterial part of the Group”. However, it will become more important when the company’s new Vietnam factory opens – see below.
I think it’s worth remembering that the sales split above reflects where Zotefoams’ manufacturing operations are, not where the resulting end products are sold by the company’s clients.
Vietnam JV: In March, Zotefoams announced plans for a major new factory in Vietnam. Today we learn that the company has found a regional partner, Seoheung Co Ltd, who will contribute $10m in return for a 17.5% equity stake in this new subsidiary.
Seoheung is a regional footwear manufacturing specialist and will have the option to increase its ownership to 35% for an additional $14m investment.
This JV looks like a sensible arrangement to me, with potential benefits for both parties:
Seoheung brings decades of experience in the Asian footwear industry, including deep knowledge of Vietnam's manufacturing landscape. The partnership supports Zotefoams' strategic evolution from supplying traditional foam sheets to producing advanced 3D preforms for the athletic footwear market.
Zotefoams has also recruited a new Managing Director for Asia, Brandon Thomas. His previous role was at Nike, serving as General Manager for Asia, based in Vietnam, so he should bring much relevant experience.
Outlook: Zotefoams says it has “entered the second half with positive momentum” and supportive trends across its markets.
However, in H2 the company expects to see some moderation (a reduction?) in Consumer & Lifestyle demand due to seasonal factors – the exceptional growth rates seen in H1 are not expected to repeat.
Even so, today’s results have given Zotefoams’ board sufficient confidence to upgrade full-year profit guidance.
The company helpfully reminds of 2025 consensus estimates (revenue £149.7m, adjusted PBT £19.4m) but does not give any clue about the new expectations.
Sadly there are no updated broker notes available for Zotefoams today on Research Tree, so we’re flying blind.
However, applying a 10% increase to current year forecasts seems plausible to me. That would suggest a FY25E earnings per share figure of perhaps 32p, leaving the stock on a P/E of 10 or less.
Roland’s view
I was positive on Zotefoams in May, highlighting improved profitability and a positive outlook.
These results highlight the improvement in profitability I was hoping to see, with a return on capital employed (excluding MEL) of 15.8% for the last 12 months. That’s up from a group figure of around 12% previously.
Today’s earnings upgrade should strengthen the stock’s momentum scores. Despite a double-digit percentage share price gain today, Zotefoams still looks quite reasonably priced to me.
The main risks I can see relate to the company’s cyclical exposure to consumer markets and its heavy customer concentration.
Sales to the group’s largest customer (unnamed, but I think it’s ultimately Nike) totalled £37m in H1, or 47.8% of revenue (H1 24: 43.7%).
There’s no escaping that Zotefoams’ fortunes are closely-linked to this one customer. To my mind, this deserves a modest valuation discount. This leaves me with a choice as to whether to maintain my fully GREEN view from May, or step down one notch to AMBER/GREEN.
I’m tempted to downgrade, but on the strength of today’s improved profitability and earnings upgrade, I’m going to stay at GREEN.
Diageo (LON:DGE)
Up %1 to 1,835p (£40.6bn) - Full year results - Roland - AMBER
Drinks giant Diageo has been a long-time Falling Star, suffering a decline that’s seen its share price fall to levels last seen almost 10 years ago. This is a remarkable decline for a company that was viewed as a high-quality defensive for so many years
The group recently ejected former CEO Debra Crew, appointing finance boss Nik Jhangiani as interim CEO. Apparently, a permanent CEO appointment is expected by October.
In the meantime, today’s results provide us with a chance to take the temperature of the business and check for any signs of a recovery in global booze purchases.
I think it’s fair to say that the news is mixed, at best:
Net sales -0.1% to $20,245m
Reported operating profit -27.8% to $4,335m
Adjusted operating profit -0.7% to $5,704m
Reported net profit -39.1% to $2,538m
Free cash flow: $2,748m
Adjusted earnings fell by 8.6% to 164.2 cents, which appears to be marginally above the consensus estimate of 161c shown in Stockopedia.
The list of exceptional adjusting items totals $1.3bn and occupies a whole page. I don’t think it’s worth dissecting in detail here, but it probably is worth highlighting the $910m impairment charge.
The largest single item within this was a $458m impairment in Distill Ventures (a discontinued accelerator programme for new brands).
Aside from this, the firm’s Aviation American Gin suffered a $231m charge (around a third of the $610m paid for this celebrity-backed brand in 2020). Elsewhere, there was a $170m charge in respect of “various other US brands” and a $50m charge against Bell’s whisky.
This table showing the sales performance of key categories has very few bright spots except tequila (mainly Don Julio) and beer (mainly Guinness):
Geographically, volumes fell by 1.2% in North America and by 4.7% in Europe. However, there were some signs of recovery in Asia Pacific (vol +3.7%) and Latin America/Caribbean (vol +3.6%). Unfortunately, North America accounts for around 40% of group sales.
Balance sheet & cash flow: as Graham pointed out in May, Diageo’s leverage has overshot its previous target, forcing the company to adopt a new guidance range and an ambition to deleverage within three years.
Today’s results contain mixed news on that front, in my view.
Net debt rose slightly to $21.9bn last year, leaving Diageo with leverage of 3.4x adjusted EBITDA. This is within the new guidance range of 3.3-3.5x adopted in May, but well above the company’s longstanding historic target range of 2.5-3.0x. A return to these levels is targeted by FY28.
Cash generation has historically been strong here and last year’s free cash flow of $2,747m represents impressive cash conversion from net profit of $2,538m.
However, my sums suggest the increased dividend of 103.48c will cost around $2,337m. That leaves very little surplus cash to fund debt reduction.
One option may be to secure further disposals and cut costs – today’s results include guidance for cost savings of $625m this year, up from $500m previously. However, I’m not sure the extra cost cutting will make that much difference, especially given the time lag and cost of implementation such changes often carry.
Outlook & Strategy: perhaps understandably, there’s no change to the group’s core strategy. This seems to involve hoping for a recovery in spirits while working on new packaging and presentation options to try and capture market share in more modern categories.
Examples mentioned today include Guinness Microdraught and a new strategy for ready-to-drink products (e.g. spirits and mixers in cans).
The company has also included more detailed financial guidance for FY26 today:
Organic sales growth similar to FY25 (+1.7%), with H2 weighting
Improvement in operating margins, with mid-single digit operating profit growth
Free cash flow of c.$3bn, aided by lower capex
Consensus forecasts prior to today suggest a 5% increase in adjusted earnings to 169c per share in FY26, pricing the stock on a P/E of 14.
Roland’s view
Diageo’s share price has fallen to a level where the dividend yield is now over 4.3% and the shares now boast a free cash flow yield over 5%.
This is a level where I’d normally see some value, given that this is a quality consumer business with 20%+ operating margins.
I’m not yet convinced about the value on offer at Diageo, though. One reason for this is that raised leverage means net finance costs are running close to $1bn per year. The dividend – which hasn’t been cut for over 20 years – leaves very little surplus cash for debt reduction.
Another potential headwind is the trend towards lower alcohol consumption and the wider use of weight-loss drugs.
I don’t know how likely it is that the recent decline in drinking will continue. But these trends do lead to a structural change in habits among a) younger drinkers and b) heavy drinkers, then they could result in a lasting change in profitability and growth potential for companies such as Diageo. Fund manager Terry Smith cited these factors when deciding to sell Diageo last year.
I’d consider myself as a potential investor in Diageo, but I don’t see enough in today’s results to tip the balance either way. At this point, I see this as a holding situation where the most sensible course of action is to maintain our neutral view.
Disclaimer
This is not financial advice. Our content is intended to be used and must be used for information and education purposes only. Please read our disclaimer and terms and conditions to understand our obligations.


40 comments
Zotefoams (LON:ZTF)
Roland
However, applying a 10% increase to current year forecasts seems plausible to me. That would suggest a FY25E earnings per share figure of perhaps 32p, leaving the stock on a P/E of 10 or less.
hmmmmm - looks like Singers upgrades are nothing like 10% (see update below i have fair use copied from the other place) - hey ho. I have it when companies leave a void in info and only the chosen brokers and their mates have an insight.
Perhaps slightly surprising that the shareprice is so strong today - hey ho "an upgrade" is an upgrade - and share was in the doldrums so reaction is not unexpected .
I suspect the market might like the fact that they are Partnering up in Vietnam - seems very sensible to me that if they can find soemone to share costs and they will likley bring in extra revenues - then sharing the secret sauce if its on largewr scale makes complete sense.
from Singers
upgrades:
FY25/26 sales by 3.3%/3.4%
FY25/26 Adj PBT by 4.6%/2.4%
Forecasts 27% EBIT growth in FY25 (helped by removal of MEL losses) and 7% in FY26.
Big reduction in net debt forecast to year-end 0.3x.
Roland, you have Amber/Green at the top of Zotefoams (LON:ZTF) report but say it is Green at the bottom.
Thanks for catching that Rusty!
Gore Street Energy Storage Fund (LON:GSF) RM webinar link- do sign up, should be interesting ! A presentation about their plans for GSF. 9.00 am tomorrow Aug 6th
For those interested Bitcoin ETFs etc should be available in the UK from 8 October. https://www.fca.org.uk/news/pr...
Not Bitcoin ETFs but ETNs
Without sounding a numpty eparo what's the difference is ETN exchange traded note or such like ?
I see that Neil Woodford has now been fined £46m. It's good to see justice served, but why on earth does it take so long?
Yep, he was fined £6m and his company £40m. Legal processes can go on for a long time.
And of course given how long the FCA allowed the Fund to be mismanaged prior to it's implosion, should we have seen them fining themselves?
Just a thought!!
Not to mention the utter mess they've created with car finance fiasco. They desperately need a clear-out - starting at the top.
I have watched GlobalData (LON:DATA), and held it for a while in the past, but am I being unfair to regard this management as being unusually clueless? This is a company in data retrieval and use - a red hot area of worldwide demand. Their share price is where it was six years ago and their ROE is a modest 13%.
Now, in the face of rapid demand for investment funds from others in the market, as they deepen the opportunities in AI and supply of data insights, DATA takes the moment to spend £60mm on a tender offer while still having long term debt. Have they really no idea how to invest £60mm while they are in markets that apparently include aerospace, defence, healthcare and agribusiness? I feel I must be missing something here.
On GlobalData (LON:DATA) The FCF ps in 2019 was 4.33 and the FCF in 24 was 4.79. All things being equal it is reasonable that the sp is about the same.
A recent article on how companies that that put out an ahead of expectation update and rise more than 10% tend to go on to outperform. Presumably Zotefoams (LON:ZTF) fits the criteria. Interestingly, while the share price is up 20% this morning it had actually fell heavily over last couple of weeks for no obvious reason so only back to where it was on 23 July.
Zotefoams (LON:ZTF) That's two out of three criteria. The third was Stock Rank > 75.
Zotefoams (LON:ZTF) A stock to keep an eye on i think. I bought back in 2023 at an SP 368. Can’t remember what put me off but sold out quite quickly. I think relying on one big client is a little tricky but I do like the direction of the new CEO. Reminds me a bit of Rolls-Royce Holdings (LON:RR.) CEO appointment. I am keeping a close eye on this one and may be looking for an entry point.
Based on FY forecast run rates for Revenue and Adj PBT of £149m and £18.7m, Zotefoams (LON:ZTF) delivered a half year beat with £61.4m and £11.4m respectively. Puts and takes include a lighter tax charge and currency headwinds.
The ‘beat and raise’ was complete with the CEO stating “full year underlying profit before taxation ahead of current market expectations.”
On the surface it looks like full steam ahead on calm waters but core longer term challenges remain, notwithstanding short-term tariff and global consumer demand uncertainty.
The beat and raise was driven by key client Nike’s decision to roll out premium ZoomX cushioning to mid tear running shoes and other sports, notably basketball. No doubt this could have further to go, though H2 demand has tempered. But the overall costs and margins relating to this relationship are not clear.
The cessation of Mucell development allowed adjusted profits to rise but investment in new facilities in the US and Vietnam kept capex up and free cash flow down.
The new Vietnam factory facility costing c$40m is being partially de-risked with a new JV partner. Alongside the $10m to $24m investment they also provide ‘production expertise’ – isn’t this Zotefoams (LON:ZTF)’s core area of expertise?
A key benefit of the JV structure is that it avoids putting pressure on the unusually structured £50m RCF bank facility, which has £29m of ‘current liability’ debt drawn. The drawn amount is ‘repayable on the last day of each loan interest period, which is either of a 3 or 6 month duration’, but secured against property, plant and equipment. No need to re-open that box of tricks.
The primary need for the Vietnam investment, to keep aligned with Nike’s supply chain and cost reduction requirements, but the ability to leverage the investments for alternative revenue sources is unclear.
The silence on the much trumpeted Shincell JV investment which sits proudly as a £5.9m liability on the balance sheet, is strange suggesting a lack of progress to report. This too was to drive growth in the Asian business. Reference to demand and cost pressures suggest the Asian growth strategy is unproven at best.
In summary, short term good, but it’s not clear how this ship will be bobbing along in 5 years time, with or without its Nike relationship in tow.
Morning Graham, all, Keller (LON:KLR) H1 results seem broadly positive. As a newbie ISA stocks investor, I'm interested to know how FX is impacting US-sales-centric Keller (LON:KLR) and how markets react in general i.e. to immediate realities of currency translation downside vs notion that companies can keep profits in US and repatriate in more favourable times hence sentiment not so bad.
Zotefoams (LON:ZTF)
Can't add much more to what has already been said. The new management team headed by Ronan Cox appear to have take some brave reasoned decisions since arriving, putting Rezorce on the back burner, re-organisng the structure of the company and investing in Vietnam in the face of Trumps tariff tantrums.
The partnership announced below is another example of forward thinking by the new management team
"5 August 2025 - Zotefoams, a world leader in supercritical foams, is pleased to announce that it has entered into a joint venture arrangement (the "Joint Venture") with Seoheung Co. Ltd. ("Seoheung"), a footwear supply chain specialist manufacturing footwear in Korea, Vietnam, Indonesia, and China, to support the construction and commissioning of its new manufacturing facility in Vietnam."
It just goes to show that a weak share price doesn't always reflect the operational performance of a company. I haven't yet looked the at the share price action this morning, but I suspect that those who sold out recently will end up paying a substantially higher price to buy back in. Fortunately I resisted the temptation and Zotefoams (LON:ZTF) continues to be held in all three family ISAs.
I would welcome the thoughts of Graham et al on this morning's interims.
All the best.
Solid/reassuring results from Naked Wines (LON:WINE) today. And they’re commencing a buyback too (hopefully the first of some pretty big distributions).
I'm hoping one of the team has time to cover Mincon and Zotefoams today, both pleasing statements, plus the Vietnam factory statement by the latter makes good sense. I tried to add to our holding on Barclays at 8.00am but couldn't get an early deal for 2500 shares until it finally offered quote and deal at 339p, I've decided to wait until better brains than mine give an opinion. It wasn't a problem to add 5,000 Mincon to an already weighty holding at 35p.
Zotefoams (LON:ZTF)
I think its all out in the open reference zotefoams - they seem to be in sweet spot at present extra capacity coming on line and rtaing undemanding at under 10 * earnings.
The partner for thew new facility should be able to hep with funding and presumably the plan is their connections ensure its running at hopefully something close to full or hoped for capacity. They are giving away fair chunk of profits that go via that facility though.
As to why the price is cheap - they have high volume of biisness with Nike - that seems to be going great - tie up is long term but big boys only partner up as long as it suits them.
Capital intensive industry always brings risks with high fixed overheads - its always great while sales are going up - can be brutal if sales ever go into reverse - ZTF are seasoned players here though.
could they ever be subject to low cost competition if someone can match the uqality of stuff they do ? are any trade secrets safe nowadays ? they do have the benefit of being trusted name
Then there is the tariffs issue - the fact they have multiple facilities included us suggests they have most bases covered.
Some here seemed worried about vietnam - hopefully tie up will convince them that side of things is not as risky as it might have been with solid partner.
Personally i bought in just befroe the ditched the blue sky stuff - i thought it was reasonably valued even if that stuff didnt take off. Wasnt expecting it be ditched super pronto but the main business has now ditched losses ref blue sky stuff - so that was kind of low risk gamble that hasnt really lost anything.
will i stay around for the long term ? who knows - companies like this can be tricky - they seem in good sweet spot and with increased production that should allow higher sales. Business like this may have peaks and troughs in then long term so its hard to know what the future holds. I have held Somero Enterprises (LON:SOM) for some time and missed a chance to sell out when they were in their sweet spot which has now passed - paper gains now being replaced by tickover dividends. I think Zotefoams (LON:ZTF) is a much better quality business though ref sales opportunities.
In summary decent business at decent price - but they need to work hard to earn their crust.
Hopefully you might have a ramble on Serica Energy (LON:SQZ) Graham its looked cheap as chips for ages but flip side has been a trail of constant delays and banana skins is todays update saying its probably best to take it off the watchlist and focus on something else ?
Capita (LON:CPI): absence of a scheduled RNS this morning:
Edit, RNS published at 07:55!
https://www.londonstockexchang...
I got it twice!
Capita (LON:CPI): absence of a scheduled RNS this morning
https://www.londonstockexchang...
timarr
Would love your view on Mincon (LON:MCON) today Graham - you've followed the company well over the years and there's hopefully a recovery play opportunity here!
Yes Tortoise, I'll be taking a look, cheers!
Mincon (LON:MCON) looks like a no-brainer. £180m of tangible assets, and £59m liabilities, with a £69m Market Cap. What am I missing?
Very strong half year figures from Zotefoams (LON:ZTF) this morning. Comfortably on track to meet full year forecasts and with a nice debt reduction plus a de-risking agreement to build their new facility in Vietnam with a local partner who will fund part of the build cost.
Zotefoams (LON:ZTF) interims - the key note here is in the outlook statement - "the Board now expects to deliver full year underlying profit before taxation ahead of current market expectations."
I missed that bit. Even better! Cheaply rated for the current growth and profits strong again now that the costs of the unfortunate Rezorce project have dropped out.
Serica Energy (LON:SQZ) bizarre choice of words from CEO. "Coiled spring" that lost £42 million. I think the market may punish him for that hubris.
Serica Energy (LON:SQZ) remember to come to me for your early morning predictions. +7% so far.
Both the CEO and I remember slinkies.
Pleasing update from Serica Energy (LON:SQZ) "like a coiled spring", even with the expected 33% cut in dividend, will still pay nearly 8% in sustained dividends for the year.
The commentary sounded great for the future, but the numbers didn't align with this for the past - production down 44%, debt remained the same, FCF dropped 86% and they made a loss of £43m vs £82m profit last HY, hence I guess why they dropped the dividend.
I like the new CEO's confidence in the future, but these results weren't great, but lets hope its now turning the corner and will deliver for us over the next couple of years - I am a holder.
Ref Serica Energy (LON:SQZ) Where does the 71m cash refund come in. Does that counteract the £43m loss or is the loss despite getting the 71m?
71m is a tax cash refund from prior year. (In PY FY results) - it’s just a BS movement this period - receivable replaced by the cash in the door. Nothing to do with financial result for this interim period.